Metabolism of amino acids in cancer

Z Wei, X Liu, C Cheng, W Yu, P Yi - Frontiers in cell and …, 2021 - frontiersin.org
Metabolic reprogramming has been widely recognized as a hallmark of malignancy. The
uptake and metabolism of amino acids are aberrantly upregulated in many cancers that …

Targeting metabolism for cancer therapy

A Luengo, DY Gui, MG Vander Heiden - Cell chemical biology, 2017 - cell.com
Metabolic reprogramming contributes to tumor development and introduces metabolic
liabilities that can be exploited to treat cancer. Chemotherapies targeting metabolism have …

Arginine signaling and cancer metabolism

CL Chen, SC Hsu, DK Ann, Y Yen, HJ Kung - Cancers, 2021 - mdpi.com
Simple Summary In this review, we describe arginine's role as a signaling metabolite,
epigenetic regulator and mitochondrial modulator in cancer cells, and summarize recent …

Autophagy maintains tumour growth through circulating arginine

L Poillet-Perez, X Xie, LE Zhan, Y Yang, DW Sharp… - Nature, 2018 - nature.com
Autophagy captures intracellular components and delivers them to lysosomes, where they
are degraded and recycled to sustain metabolism and to enable survival during starvation …

Arginine dependence of tumor cells: targeting a chink in cancer's armor

MD Patil, J Bhaumik, S Babykutty, UC Banerjee… - Oncogene, 2016 - nature.com
Arginine, one among the 20 most common natural amino acids, has a pivotal role in cellular
physiology as it is being involved in numerous cellular metabolic and signaling pathways …

Systemic immunometabolism: challenges and opportunities

A Lercher, H Baazim, A Bergthaler - Immunity, 2020 - cell.com
Over the past 10 years, the field of immunometabolism made great strides to unveil the
crucial role of intracellular metabolism in regulating immune cell function. Emerging insights …

[HTML][HTML] Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced …

GK Abou-Alfa, S Qin, BY Ryoo, SN Lu, CJ Yen… - Annals of …, 2018 - Elsevier
Background Arginine depletion is a putative target in hepatocellular carcinoma (HCC). HCC
often lacks argininosuccinate synthetase, a citrulline to arginine-repleting enzyme. ADI-PEG …

[HTML][HTML] Arginine metabolism and deprivation in cancer therapy

S Zou, X Wang, P Liu, C Ke, S Xu - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Highlights•Reviewed the function of arginine and its metabolites in arginine deprivation
therapy.•Discussed the difference of arginine deiminase and recombinant human arginase …

Metabolic pathways of L-arginine and therapeutic consequences in tumors

J Szefel, A Danielak, WJ Kruszewski - Advances in medical sciences, 2019 - Elsevier
Difference in the metabolism of normal and cancer cells inspires to search for new, more
specific and less toxic therapies than those currently used. The development of tumors is …

Arginine deprivation with pegylated arginine deiminase in patients with argininosuccinate synthetase 1–deficient malignant pleural mesothelioma: a randomized …

PW Szlosarek, JP Steele, L Nolan, D Gilligan… - JAMA …, 2017 - jamanetwork.com
Importance Preclinical studies show that arginine deprivation is synthetically lethal in
argininosuccinate synthetase 1 (ASS1)-negative cancers, including mesothelioma. The role …